Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

John C. Reed

At a glance: John C. Reed is Evp, Innovative Medicine, R&D at Johnson & Johnson (JNJ). Their latest SEC Form 4, filed Feb 18, 2026, reported a sale of $5.3M. On file: 0 purchase lines ($0) and 4 sale lines ($17.3M).

Disclosed holdings: about $2.8M of JNJ stock: 10,658 shares reported on their latest Form 4 (filed Feb 18, 2026), valued at the Nov 19, 2026 close of $267.11. This counts only JNJ shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp, Innovative Medicine, R&D at Johnson & Johnson (JNJ)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $17.3M

John C. Reed's InsiderPrint

4 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of John C. Reed: 4 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 3 sales

Reading this print: Almost only sells, trading about 4 times a year, typically $5.3M a trade.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (4)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. David A. ZapicoCEO · AME · 100% match
  2. Jennifer ZacharyGeneral Counsel · MRK · 100% match
  3. Ryan HickeCEO · SEIC · 100% match
  4. Douglas C. Yearley Jr.CEO · TOL · 100% match
  5. Rochester Regional Joint Board Fund For The Future10% Owner · AMAL · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Feb 18SEC JNJJohnson & Johnson Sell 21,72112,941 held (−63%) $243.00 $5.3M +9.9%
Feb 18SEC JNJJohnson & Johnson Sell 29,92712,941 held (−70%) $243.00 $7.3M +9.9%
Feb 18SEC JNJJohnson & Johnson Sell 2,28310,658 held (−18%) $243.00 $555K +9.9%
Oct 20SEC JNJJohnson & Johnson Sell 21,72110,658 held (−67%) $192.71 $4.2M +38.6%
  • Sell

    Evp, Innovative Medicine, R&D John C Reed sold $5.3M of JNJ at $243.00 — cuts the stake by 63%.

  • Sell

    Evp, Innovative Medicine, R&D John C Reed sold $7.3M of JNJ at $243.00 — cuts the stake by 70%.

  • Sell

    Evp, Innovative Medicine, R&D John C Reed sold $4.2M of JNJ at $192.71 — cuts the stake by 67%.

Follow John C. Reed

Get one email when John C. Reed files a new purchase or sale. Free.

At most one email a day about John C. Reed, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.